TRPS1 drives heterochromatic origin refiring and cancer genome evolution
Summary: Exploitation of naturally occurring genetic mutations could empower the discovery of novel aspects of established cancer genes. We report here that TRPS1, a gene linked to the tricho-rhino-phalangeal syndrome (TRPS) and recently identified as a potential breast cancer driver, promotes breas...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124721001285 |
id |
doaj-b658d630f0974c88869c1af9df9bf455 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jianguo Yang Xiaoping Liu Yunchao Huang Lin He Wenting Zhang Jie Ren Yue Wang Jiajing Wu Xiaodi Wu Lin Shan Xiaohan Yang Luyang Sun Jing Liang Yu Zhang Yongfeng Shang |
spellingShingle |
Jianguo Yang Xiaoping Liu Yunchao Huang Lin He Wenting Zhang Jie Ren Yue Wang Jiajing Wu Xiaodi Wu Lin Shan Xiaohan Yang Luyang Sun Jing Liang Yu Zhang Yongfeng Shang TRPS1 drives heterochromatic origin refiring and cancer genome evolution Cell Reports heterochromatic origin refiring TRPS1 H3K9me3 breast cancer cancer genome evolution therapeutic resistance |
author_facet |
Jianguo Yang Xiaoping Liu Yunchao Huang Lin He Wenting Zhang Jie Ren Yue Wang Jiajing Wu Xiaodi Wu Lin Shan Xiaohan Yang Luyang Sun Jing Liang Yu Zhang Yongfeng Shang |
author_sort |
Jianguo Yang |
title |
TRPS1 drives heterochromatic origin refiring and cancer genome evolution |
title_short |
TRPS1 drives heterochromatic origin refiring and cancer genome evolution |
title_full |
TRPS1 drives heterochromatic origin refiring and cancer genome evolution |
title_fullStr |
TRPS1 drives heterochromatic origin refiring and cancer genome evolution |
title_full_unstemmed |
TRPS1 drives heterochromatic origin refiring and cancer genome evolution |
title_sort |
trps1 drives heterochromatic origin refiring and cancer genome evolution |
publisher |
Elsevier |
series |
Cell Reports |
issn |
2211-1247 |
publishDate |
2021-03-01 |
description |
Summary: Exploitation of naturally occurring genetic mutations could empower the discovery of novel aspects of established cancer genes. We report here that TRPS1, a gene linked to the tricho-rhino-phalangeal syndrome (TRPS) and recently identified as a potential breast cancer driver, promotes breast carcinogenesis through regulating replication. Epigenomic decomposition of TRPS1 landscape reveals nearly half of H3K9me3-marked heterochromatic origins are occupied by TRPS1, where it encourages the chromatin loading of APC/C, resulting in uncontrolled origin refiring. TRPS1 binds to the genome through its atypical H3K9me3 reading via GATA and IKAROS domains, while TRPS-related mutations affect its chromatin binding, replication boosting, and tumorigenicity. Concordantly, overexpression of wild-type but not TRPS-associated mutants of TRPS1 is sufficient to drive cancer genome amplifications, which experience an extrachromosomal route and dynamically evolve to confer therapeutic resistance. Together, these results uncover a critical function of TRPS1 in driving heterochromatin origin firing and breast cancer genome evolution. |
topic |
heterochromatic origin refiring TRPS1 H3K9me3 breast cancer cancer genome evolution therapeutic resistance |
url |
http://www.sciencedirect.com/science/article/pii/S2211124721001285 |
work_keys_str_mv |
AT jianguoyang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT xiaopingliu trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT yunchaohuang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT linhe trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT wentingzhang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT jieren trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT yuewang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT jiajingwu trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT xiaodiwu trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT linshan trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT xiaohanyang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT luyangsun trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT jingliang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT yuzhang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution AT yongfengshang trps1drivesheterochromaticoriginrefiringandcancergenomeevolution |
_version_ |
1724226059314921472 |
spelling |
doaj-b658d630f0974c88869c1af9df9bf4552021-03-11T04:24:37ZengElsevierCell Reports2211-12472021-03-013410108814TRPS1 drives heterochromatic origin refiring and cancer genome evolutionJianguo Yang0Xiaoping Liu1Yunchao Huang2Lin He3Wenting Zhang4Jie Ren5Yue Wang6Jiajing Wu7Xiaodi Wu8Lin Shan9Xiaohan Yang10Luyang Sun11Jing Liang12Yu Zhang13Yongfeng Shang14Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Medicine, Hangzhou Normal University, Hangzhou 311121, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China; Corresponding authorDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Health Science Center, Beijing 100191, China; Department of Biochemistry and Molecular Biology, School of Medicine, Hangzhou Normal University, Hangzhou 311121, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China; Corresponding authorSummary: Exploitation of naturally occurring genetic mutations could empower the discovery of novel aspects of established cancer genes. We report here that TRPS1, a gene linked to the tricho-rhino-phalangeal syndrome (TRPS) and recently identified as a potential breast cancer driver, promotes breast carcinogenesis through regulating replication. Epigenomic decomposition of TRPS1 landscape reveals nearly half of H3K9me3-marked heterochromatic origins are occupied by TRPS1, where it encourages the chromatin loading of APC/C, resulting in uncontrolled origin refiring. TRPS1 binds to the genome through its atypical H3K9me3 reading via GATA and IKAROS domains, while TRPS-related mutations affect its chromatin binding, replication boosting, and tumorigenicity. Concordantly, overexpression of wild-type but not TRPS-associated mutants of TRPS1 is sufficient to drive cancer genome amplifications, which experience an extrachromosomal route and dynamically evolve to confer therapeutic resistance. Together, these results uncover a critical function of TRPS1 in driving heterochromatin origin firing and breast cancer genome evolution.http://www.sciencedirect.com/science/article/pii/S2211124721001285heterochromatic origin refiringTRPS1H3K9me3breast cancercancer genome evolutiontherapeutic resistance |